Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT02015520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Clazakizumab in Subjects With Moderate to Severe Active Rheumatoid Arthritis Who Have Experienced an Inadequate Response to TNF Inhibitors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to identify an appropriate dose of study medication.
Study identification
- NCT ID
- NCT02015520
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2012
- Primary completion
- May 31, 2013
- Completion
- May 31, 2015
- Last update posted
- May 11, 2021
2012 – 2015
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates Of North Alabama, P.C. | Huntsville | Alabama | 35801 | — |
| Mercy Clinic Hot Springs Communities | Hot Springs | Arkansas | 71913 | — |
| Valerius Med Group & Res Ctr Of Greater Long Beach, Inc. | Long Beach | California | 90806 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| Sarasota Arthritis Research Center | Sarasota | Florida | 34239 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| St. Paul Rheumatology, P.A. | Eagan | Minnesota | 55121 | — |
| Physician Research Collaboration, Llc | Lincoln | Nebraska | 68516 | — |
| Albuquerque Center For Rheumatology | Albuquerque | New Mexico | 87102 | — |
| Albuquerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| Joint And Muscle Medical Care And Research Institute (Jmmcri) | Charlotte | North Carolina | 28204 | — |
| Physicians East, Pa | Greenville | North Carolina | 27834 | — |
| Cincinnati Rheumatic Disease Study Group | Cincinnati | Ohio | 45219 | — |
| Paramount Medical Research & Consulting, Llc | Middleburg Heights | Ohio | 44130 | — |
| Arthritis & Rheumatology Center Of Oklahoma Pllc | Oklahoma City | Oklahoma | 73103 | — |
| Health Research Of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Healthcare Research Consultants | Tulsa | Oklahoma | 74135 | — |
| Low Country Rheumatology | Charleston | South Carolina | 29406 | — |
| Rheumatology Consultants Pllc | Knoxville | Tennessee | 37909 | — |
| Center For Inflammatory Disease | Nashville | Tennessee | 37203 | — |
| Seattle Rheumatology Associates | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02015520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02015520 live on ClinicalTrials.gov.